Companies:
49,829
Total Market Cap:
139401233083420.00
Global Rank
#49419
Country Rank
#6515
Market Cap
3,213
Price
0.0001
Change (%)
0.00%
Volume
134
Rebus Holdings's latest marketcap:
3,213
As of 07/05/2025, Rebus Holdings's market capitalization has reached $3,213. According to our data, Rebus Holdings is the 49419th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 3,213 |
| Revenue (ttm) | 0 |
| Net Income (ttm) | 570,000 |
| Shares Out | 32.13 M |
| EPS (ttm) | 0.02 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | n/a |
Market Cap Chart
Data Updated: 07/05/2025
Rebus Holdings's yearly market capitalization.
Rebus Holdings has seen its market value drop from $20.52 M to $3,213 since 2014, representing a total decrease of 99.98% and an annual compound decline rate (CAGR) of 56.55%.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | $3,213 | 9940.62% | 49419 |
| 12/31/2024 | $32 | -99.98% | 48441 |
| 12/29/2023 | $162,271 | -32.67% | 46766 |
| 12/30/2022 | $240,997 | -12.12% | 45023 |
| 12/31/2021 | $274,225 | -69.91% | 42988 |
| 12/31/2020 | $911,250 | 1469.71% | 39751 |
| 12/31/2019 | $58,052 | 30.42% | 37037 |
| 12/31/2018 | $44,511 | -81.38% | 35634 |
| 12/29/2017 | $239,064 | -67.8% | 34101 |
| 12/30/2016 | $742,503 | -87.1% | 32063 |
Company Profile
About Rebus Holdings, Inc.
Rebus Holdings, Inc., together with its subsidiaries, is a biotechnology company dedicated to advancing precision therapeutics for cancer treatment.
Key Focus Areas
- Lead Asset: RT-AR001, an adenosine receptor antagonist designed to enhance tumor infiltration and improve treatment outcomes when administered intra-tumorally.
- Research & Development: Specializes in innovative therapies targeting cancer with a focus on precision medicine.
Company Overview
Founded in 2003, Rebus Holdings, Inc. is headquartered in Westlake Village, California, and continues to drive advancements in oncology therapeutics.
Frequently Asked Questions
-
What is Rebus Holdings's (OTC-RBSH) current market cap?As of 07/05/2025, Rebus Holdings (including the parent company, if applicable) has an estimated market capitalization of $3,213 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Rebus Holdings (OTC-RBSH) rank globally by market cap?Rebus Holdings global market capitalization ranking is approximately 49419 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.